Onyx Healthcare (ROCO:6569) Marketable Securities: NT$8 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6569 Onyx Healthcare Inc ROCO:6569
76 GF Score
Price NT$97.80
GF Value NT$129.13
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Onyx Healthcare Marketable Securities?

Onyx Healthcare ROCO:6569 -0.61% 76 Marketable Securities is NT$8 Mil as of Mar. 2026. GuruFocus rates ROCO:6569 with a GF Score™ of 76/100 and a GF Value™ of NT$129.13 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Onyx Healthcare's Marketable Securities for the quarter that ended in Mar. 2026 was NT$8 Mil.

Onyx Healthcare's annual Marketable Securities declined from Dec. 2023 (NT$43 Mil) to Dec. 2024 (NT$8 Mil) and declined from Dec. 2024 (NT$8 Mil) to Dec. 2025 (NT$8 Mil).

Onyx Healthcare  (ROCO:6569) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Onyx Healthcare Marketable Securities Related Terms

Onyx Healthcare Marketable Securities Historical Data

* Premium members only.

The historical data trend for Onyx Healthcare's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Healthcare Marketable Securities Chart

Onyx Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.13 7.21 43.02 8.24 8.16

Onyx Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.56 8.19 7.62 8.16 8.03
ROCO:6569
76GF Score
Onyx Healthcare Inc ROCO:6569
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onyx Healthcare Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of NT$8 Mil mean?
Onyx Healthcare (ROCO:6569) has a Marketable Securities of NT$8 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Onyx Healthcare and its competitors.
Is Onyx Healthcare's Marketable Securities too high?
Onyx Healthcare's current Marketable Securities is NT$8 Mil. Overall, Onyx Healthcare has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's Marketable Securities compare to VEEV and BTSG?
Onyx Healthcare's Marketable Securities of NT$8 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Onyx Healthcare and its competitors. Onyx Healthcare's current Marketable Securities is NT$8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$129.13, compared to a current price of NT$97.80 — trading 24.3% below its estimated fair value. The current Marketable Securities is NT$8 Mil. Onyx Healthcare's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current Marketable Securities is NT$8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?

Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued. The current stock price of NT$97.80 is trading 24.3% below its estimated GF Value™ of NT$129.13. GuruFocus considers Onyx Healthcare to be Modestly Undervalued.

Key valuation signals for ROCO:6569:

  • Marketable Securities: NT$8 Mil
  • GF Value™: NT$129.13 vs. price of NT$97.80 (24.3% below fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Onyx Healthcare Business Description

Address No. 135, Lane 235, Baoqiao Road, 4th Floor, Xindian District, New Taipei, TWN, 231028
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
76GF Score

Get the complete analysis for ROCO:6569

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$97.80
Price
NT$129.13
GF Value